Carmel Pharma

Carmel Pharma, Inc. Launches New PhaSeal Preparation Component

Carmel Pharma, Inc. launches their new Protector 28 (P28). This preparation component is the latest advancement of the PhaSeal System and is available now.

Columbus, OH, May 03, 2007 --( With the introduction of the new P28, which is compatible with 28 mm neck size drug vials, PhaSeal is the only universally compatible closed-system drug transfer device available for all brands of infusion sets and all standard size drug vials.

The PhaSeal System is the only clinically proven closed-system drug transfer device available today. The System consists of an Expansion Chamber that captures aerosols and vapors while equalizing the pressure in the vial, a Double membrane that ensures dry connections, and a Needle-Safe Design that enables the retrieval of all the drug from the vial. With over 10 peer-reviewed, independent studies currently available, PhaSeal has been distinguished by prominent thought leaders as the “Gold Standard” in the safe handling arena.

The PhaSeal System is manufactured in Gothenburg, Sweden and is distributed from its U.S. affiliate office in Columbus, OH. PhaSeal has been in use in the U.S. since 2000 and has been implemented in over 500 cancer facilities in the United States, including M.D. Anderson in Houston, TX, Texas Children’s and UCSF. If you have questions regarding the PhaSeal System or Carmel Pharma, Inc., please contact Christine Crooks, Director of Marketing at 1-866-487-9250 ext.202, or online at

Carmel Pharma, Inc.
Christine Crooks